Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Amanda Brown
Senior Associate Corporate & Finance
-
Overview
-
Experience
-
Credentials
-
Insights and events
Using her innovative thinking and deep technical knowledge, Amanda Brown (Garger) delivers practical advice to both public and private companies throughout various industries and sectors.
In her practice, Amanda represents a wide range of public and private companies - from clinical-stage life sciences companies to some of the world's largest public companies - and provides trusted advice on matters related to ongoing reporting obligations under U.S. securities laws and regulations, capital market offerings (IPOs, ATMs, RDOs, PIPEs, and convertible notes, among others), corporate governance matters, and more.
Before joining Hogan Lovells, Amanda worked at the Philadelphia headquarters of an international law firm where she advised clients on a range of corporate and securities matters. While in law school, Amanda served as senior staff writer at the Villanova Law Review.
Representative experience
A large publicly traded retailer in its ongoing disclosure and reporting obligations.*
A large publicly traded reinsurance company in its ongoing disclosure and reporting obligations and its capital markets transactions.*
A private company in over 10 separate portfolio acquisitions.*
Several clinical and commercial-stage life sciences companies in at-the-market equity offerings led by Jefferies, Cowen & Company, Cantor Fitzgerald, JMP Securities and RBC Capital Markets.
A de-SPAC company in all areas of public company reporting, including on SEC and Nasdaq-related matters.
Enstar Group Limited in two senior notes offerings (each US$500 million) and two junior subordinated notes offerings (US$500 million and US$350 million).
OptiNose in its US$55 million registered direct offering.
Perspective Therapeutics in its US$80 million underwritten offering of equity securities.
Perspective Therapeutics in its US$87.4 million private placement financing.
Perspective Therapeutics on its US$69 million follow-un public offering of equity securities.
Perspective Therapeutics its series of strategic transactions with Lantheus.
Credentials
Education
- J.D., Villanova University School of Law, magna cum laude, Order of the Coif, 2016
- B.S. Marketing, University of Delaware, 2013
Bar admissions and qualifications
- Pennsylvania
- New Jersey
Publications
News
Press releases
03 June 2024
Press releases
28 May 2024
Press releases
06 March 2024